X

Stay Connected

Sign Up for Updates

 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Medicare Monday: Beware! Scary proposed changes to Medicare are out there

By Allyson Funk  |    October 31, 2016
This Halloween, beware of the spooky proposals some have put forward to change how Medicare covers prescription medicines for seniors and people living with disabilities. Tricks like these are no...   Read More

4 things to think about when choosing your health plan

By Allyson Funk  |    October 28, 2016
Open enrollment is upon us once again. Whether you are picking a plan through your employer or a health insurance marketplace, whether you are getting coverage for the first time or changing to a new...   Read More

ICYMI: Data find provider consolidation increases health care costs

By Allyson Funk  |    October 26, 2016
There is a growing body of research on the impact of health care provider consolidation on overall health care spending. In case you missed it, a recent issue brief from the National Institute for...   Read More

Medicare Monday: How to switch plans during open enrollment

By Allyson Funk  |    October 24, 2016
We’ve talked before about the importance of considering options and switching plans during open enrollment. One recent study noted beneficiaries can save an average of $400 to $600 per year by...   Read More

Study highlights negative impact of Canada's promise doctrine on R and D investment

By Mark Grayson  |    October 21, 2016
A newly published study from Charles River Associates (CRA) has found that Canada’s approach to intellectual property (IP), innovation and patient care is being jeopardized because of its adoption...   Read More

Stakeholders raise concerns about ICER’s evidence report for non-small cell lung cancer

By Lauren Neves  |    October 20, 2016
The value of recent advances in non-small cell lung cancer (NSCLC) is undeniable. NSCLC is a devastating illness – 17.7 percent of lung cancer patients survive only five years following their...   Read More

Medicare Monday: A Medicare open enrollment checklist

By Nicole Longo  |    October 17, 2016
Last week, we highlighted some tools to use during Medicare open enrollment, but how do you know if you’re choosing the right plan?   Read More

New report highlights impact of intellectual property on U.S. economy

By Mark Grayson  |    October 13, 2016
In late September, the U.S. Department of Commerce released a comprehensive report that found intellectual property (IP) intensive industries contribute more than $6 trillion (38.2 percent) to U.S....   Read More

New Spanish-language resources added to ABCs En Español

By Nicole Longo  |    October 13, 2016
With Hispanic Heritage Month coming to a close, we wanted to highlight two new videos that have been added to our Spanish-language resources microsite, AccessBetterCoverage.org/espanol.   Read More

New Study: Substantial rebates negotiated in Medicare Part D

By Allyson Funk  |    October 12, 2016
A new QuintilesIMS Institute research brief takes a first-of-its-kind look at Part D costs after accounting for rebates across 12 therapeutic classes widely used in Part D. This new report confirms...   Read More

Medicare Monday: Open enrollment starts this weekend

By Nicole Longo  |    October 10, 2016
Believe it or not, we’re almost halfway through October which means Medicare Open Enrollment is rapidly approaching. Starting Saturday, October 15, through Wednesday, December 7, newly qualified...   Read More

What are REMS? These extra steps are helping protect patient health

By Bill Chin, M.D.  |    October 6, 2016
As a physician and chief medical officer at PhRMA, I know how important it is to ensure that patients have access to safe, innovative medicines to help them live longer, healthier lives. But equally...   Read More

Ask About Adherence: How poorly managed blood pressure is placing older Americans at risk for heart disease and stroke

By Carolyn Ha  |    October 5, 2016
Ask About Adherence is a blog series featuring Q&A’s with experts and new medication adherence resources. In this post, we feature a recently released report from the Centers for Disease Control and...   Read More

340B Spotlight: Program continues to grow with no end in sight

By Rebecca Davison  |    October 4, 2016
How much is the 340B program growing? Earlier this year, Drug Channels published new 340B purchase data from Apexus, the 340B program’s Prime Vendor.  Apexus’s data show $12 billion of drug sales at...   Read More

Panel releases best practices in cost-effectiveness analysis

By Lauren Neves  |    October 3, 2016
Recently, the Journal of the American Medical Association (JAMA) published findings and recommendations from the Second Panel on Cost-Effectiveness in Health and Medicine, detailing what the authors...   Read More

Medicare Monday: How MedPAC recommendations would actually increase beneficiary costs

By Nicole Longo  |    October 3, 2016
In April, the Medicare Payment Advisory Commission (MedPAC) voted on and approved a number of harmful Medicare Part D recommendations that were then presented to Congress in MedPAC’s June report. As...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates